| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 14 | -89K | 100% | $5.99 | -$533K |
| Net | -14 | -89K | -100% | -$533K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew C. Kapusta | CEO, Managing Director, Director | $3.82M | -$177K | -4.43% | Mar 1, 2024 |
| Ricardo Dolmetsch | President, R&D | $1.22M | -$43.6K | -3.45% | Sep 18, 2023 |
| Christian Klemt | Chief Financial Officer | $791K | -$109K | -12.1% | Jun 17, 2024 |
| Alexander Edward Kuta III | Executive VP, Operations | $674K | Mar 7, 2023 | ||
| Pierre Caloz | Chief Operating Officer | $557K | -$75.3K | -11.9% | Jun 17, 2024 |
| Walid Abi-Saab | Chief Medical Officer | $503K | -$6.31K | -1.24% | Jun 26, 2024 |
| Jeannette Potts | Chief Legal Officer | $457K | -$23.8K | -4.95% | Jun 13, 2024 |
| Robert Gut | Director | $251K | -$17.9K | -6.66% | Jun 19, 2024 |
| Madhavan Balachandran | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
| Jeremy P. Springhorn | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
| David D. Meek | Director | $136K | -$11.4K | -7.73% | Jun 19, 2024 |
| Leonard E. Post | Director | $116K | -$11.4K | -8.98% | Jun 19, 2024 |
| Rachelle Suzanne Jacques | Director | $108K | -$11.4K | -9.55% | Jun 19, 2024 |
| Paula Soteropoulos | Director | $104K | -$11.4K | -9.9% | Jun 13, 2024 |
| Jack Kaye | Director | $70.1K | -$11.4K | -14% | Jun 19, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|